Free Trial

Baillie Gifford & Co. Sells 6,504 Shares of Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Baillie Gifford & Co. decreased its holdings in Exelon Co. (NASDAQ:EXC - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 86,030 shares of the company's stock after selling 6,504 shares during the quarter. Baillie Gifford & Co.'s holdings in Exelon were worth $3,238,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Foundations Investment Advisors LLC grew its stake in shares of Exelon by 3.5% in the third quarter. Foundations Investment Advisors LLC now owns 7,533 shares of the company's stock worth $305,000 after purchasing an additional 255 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in shares of Exelon by 1.0% in the third quarter. Harbor Capital Advisors Inc. now owns 28,392 shares of the company's stock worth $1,151,000 after purchasing an additional 274 shares during the last quarter. Rosenberg Matthew Hamilton lifted its holdings in Exelon by 12.6% in the fourth quarter. Rosenberg Matthew Hamilton now owns 2,457 shares of the company's stock valued at $92,000 after buying an additional 275 shares during the period. Ballentine Partners LLC lifted its holdings in Exelon by 2.1% in the third quarter. Ballentine Partners LLC now owns 13,922 shares of the company's stock valued at $565,000 after buying an additional 285 shares during the period. Finally, Wesbanco Bank Inc. lifted its holdings in Exelon by 3.1% in the fourth quarter. Wesbanco Bank Inc. now owns 9,951 shares of the company's stock valued at $375,000 after buying an additional 296 shares during the period. Institutional investors own 80.92% of the company's stock.

Exelon Stock Up 0.5 %

Shares of NASDAQ EXC traded up $0.22 during trading on Friday, hitting $43.39. 13,604,617 shares of the company traded hands, compared to its average volume of 7,215,975. The business's fifty day moving average is $39.41 and its 200 day moving average is $39.10. Exelon Co. has a fifty-two week low of $34.01 and a fifty-two week high of $43.69. The firm has a market capitalization of $43.62 billion, a price-to-earnings ratio of 17.71, a P/E/G ratio of 2.86 and a beta of 0.56. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.78 and a current ratio of 0.87.

Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same quarter last year, the company earned $0.60 EPS. Equities research analysts predict that Exelon Co. will post 2.64 earnings per share for the current fiscal year.

Exelon Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.69%. The ex-dividend date is Monday, February 24th. This is a positive change from Exelon's previous quarterly dividend of $0.38. Exelon's dividend payout ratio is currently 62.04%.

Insider Buying and Selling

In related news, EVP Colette D. Honorable sold 1,463 shares of the company's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the sale, the executive vice president now owns 2,271 shares in the company, valued at $92,134.47. This represents a 39.18 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on EXC. Barclays dropped their target price on shares of Exelon from $44.00 to $42.00 and set an "overweight" rating on the stock in a report on Wednesday, January 22nd. Morgan Stanley dropped their target price on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating on the stock in a report on Friday, November 22nd. Evercore ISI upgraded shares of Exelon from an "in-line" rating to an "outperform" rating and boosted their target price for the company from $43.00 to $44.00 in a report on Tuesday, January 21st. Scotiabank boosted their target price on shares of Exelon from $42.00 to $44.00 and gave the company a "sector perform" rating in a report on Thursday, February 13th. Finally, Guggenheim upgraded shares of Exelon from a "neutral" rating to a "buy" rating in a report on Thursday, January 23rd. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $43.38.

Check Out Our Latest Stock Report on EXC

Exelon Company Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

5 Stocks to BUY NOW in February 2025

5 Stocks to BUY NOW in February 2025

With the market holding strong, inflation concerns persisting, and major earnings reports ahead, these stock picks could be game-changers for your portfolio!

Related Videos

Risk vs. Reward: Why Analysts Predict Big Gains for Struggling SMCI

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines